公司资料
AstraZeneca PLC 股价、新闻与催化剂
- 股票代码:
- AZN
- 交易所:
- NASDAQ
- 行业:
- Small Molecule Drugs, Biologics
- 所在地:
- UK
股票表现
166.14 USD (+2.00%)
收盘价
最后更新: 2026年9月17日
275B USD
市值
股价为何变动
截至 2026年9月17日，AZN 上涨 2.00%，收于 $166.14。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
AstraZeneca is a global biopharmaceutical company with deep exposure to oncology, cardiovascular, renal, metabolic disease, respiratory, and rare disease. The company has become one of the market’s strongest large-cap growth stories.
所在地与行业分类
Headquartered in the UK and listed on the U.S. as an ADR, AstraZeneca has a global operating footprint across major healthcare markets. It is a multinational biopharma with broad therapeutic reach.
商业模式特征
AstraZeneca relies on blockbuster medicines, strong launch execution, and a pipeline that continues to refresh growth. Investors watch oncology momentum, pipeline readouts, and whether new launches can sustain the company’s growth profile.
生物医药行业定位
AstraZeneca sits near the top of the large-cap biotech/pharma landscape because it combines scale, growth, and strong R&D execution. It is less binary than smaller biotechs but still highly reactive to major oncology and pipeline news.
未来催化剂
- AstraZeneca’s watchlist should stay on camizestrant, datopotamab deruxtecan, and other late-stage oncology assets that can prove the company still has multiple shots on goal. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name ahead of the following catalyst.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。